IPO Plus - IPO

Name▼ / Code▼	Industry	Offer Price	Lot Size	Entry Fee	Closing Date	Grey Market Date▼	Listing Date▲
BrainAurora-B 06681.HK	Biotechnology - Supplies & Services	3.22	1,000	N/A	2025/01/03	2025/01/07	2025/01/08
Numans Health Food 02530.HK	Health Care Supplies	0.8-1.09	8,000	8,808	2025/01/07	2025/01/09	2025/01/10
Yibin Bank 02596.HK	Diversified Banks	2.59-2.72	1,000	2,747	2025/01/08	2025/01/10	2025/01/13

Name▼

Code▼

Industry

Offer Price

Lot Size

Entry Fee

Closing Date

Grey Market Date▼

Listing Date▲

BrainAurora-B
06681.HK

Biotechnology - Supplies & Services

3.22

1,000

N/A

2025/01/03

2025/01/07

2025/01/08

Numans Health Food
02530.HK

Health Care Supplies

0.8-1.09

8,000

8,808

2025/01/07

2025/01/09

2025/01/10

Yibin Bank
02596.HK

Diversified Banks

2.59-2.72

1,000

2,747

2025/01/08

2025/01/10

2025/01/13

Summary

We are a newly incorporated special purpose acquisition company incorporated on 11 January 2022 as a Cayman Islands exempted company with limited liability for the purpose of effecting a De-SPAC Transaction. We have not selected any specific De-SPAC Target and we have not, nor has anyone on our behalf, initiated or engaged in any substantive discussions, directly or indirectly, with any De-SPAC Target with respect to a De-SPAC Transaction with us. Our Promoters are Primavera US LLC and ABCI AM. Our strategy is to invest in high-growth companies focused on Greater China in the sectors of innovative technology, consumer and new retail, advanced manufacturing, healthcare and climate action. Our investment strategy reflects our confidence in continued growth in Greater China driven by positive macro trends in consumption upgrade, urbanisation, technology innovation and de-carbonisation. We believe our Promoters’ and their affiliates’ track records, management teams, execution and value-creation capabilities, along with their extensive network of business contacts and relationships, provide a significant advantage in identifying attractive opportunities that can deliver attractive returns to our Shareholders. Our Promoters and Affiliates Our Promoters are Primavera US LLC and ABCI AM. As at the date of this Listing Document, 60% of our issued Class B Shares are held by Primavera LLC, which is a wholly owned subsidiary of Primavera US LLC. The remaining 40% of our issued Class B Shares are held by ABCI AM Acquisition, which is a wholly owned subsidiary of ABCI AM. Primavera US LLC is an affiliate of Primavera, and ABCI AM is the offshore asset management platform of ABCI, which is the international investment banking business of ABC. Our Promoters and their affiliates have a long-established collaboration with each other, including pursuing investment opportunities together, and have benefited from the combination of their respective expertise and specialty in the capital markets, asset management, investment know-how and value creation. Primavera Primavera US LLC Primavera US LLC was established by the partners of a private equity fund group, Primavera. Dr. Fred Hu is the single largest shareholder of Primavera US LLC and Primavera. Primavera US LLC is managed directly by the individuals who manage Primavera. The key management authority of Primavera US LLC is undertaken by its sole managing member, Dr. Fred Hu, who is responsible for its overall strategy and oversees its key investments, including investment in SPACs and de-SPAC targets; and its executive manager, Mr. Chen Tong, who is responsible for executing transactions, including SPAC IPO and de-SPAC transaction, and sourcing investment opportunities and de-SPAC targets. Dr. Fred Hu is the founder and chairman of Primavera responsible for its overall strategy and oversees all the major investment transactions of Primavera; while Mr. Chen Tong is a partner and founding member of Primavera responsible for sourcing and executing a number of key transactions. The secretary of Primavera US LLC, Mr. Ge Chengyuan, is a key investment professional of Primavera, experienced in executing private equity and venture capital investments. Mr. Chen Tong and Mr. Ge Chengyuan are nominated by Primavera US LLC as executive Directors to the Board of the Company. For more information on Mr. Chen Tong and Mr. Ge Chengyuan, see ‘‘— Directors and Senior Management’’. Primavera US LLC has previous experience in SPAC issuance in the United States. See ‘‘Business — Previous SPAC Experience of Primavera US LLC’’ for further details. Primavera Primavera, being a group of entities affiliated with Primavera US LLC, is a leading China-based alternative investment management firm with offices in Beijing, Hong Kong, Singapore and Palo Alto. Primavera manages funds for prominent financial institutions, sovereign wealth funds, pension plans, endowments, corporations and family offices. Primavera employs a flexible investment strategy comprising buy-out/control-oriented growth capital and restructuring investments, driven by China’s pivotal role as the biggest emerging market in the global economy. Primavera has extensive experience in structuring and executing significant investment transactions and a SPAC issuance. Primavera seeks to create long-term value for its portfolio companies by combining deep local connectivity in Greater China with global experience and best practises. Since inception, Primavera has invested in more than 70 companies across multiple USD and RMB funds. It had assets under management of over US$17 billion as at 30 September 2021. Leveraging its stature and reputation in Greater China and an experienced investment team, Primavera has led investments in a number of renowned domestic and international companies, including XPeng (NYSE: XPEV; 9868.HK), Yum China (NYSE: YUMC; 9987.HK) and Alibaba (NYSE: BABA; 9988.HK). ABCI AM ABCI AM, the asset management arm of ABCI, was founded in 2011 and has extensive experience in the asset management business. ABCI AM is licenced by the SFC to carry out Type 4 (advising on securities) and Type 9 (asset management) regulated activities in Hong Kong, which became effective on 11 November 2013 and 18 October 2012, respectively. ABCI AM offers products in the primary and secondary markets, providing customers with a full range of professional investment and investment advisory services. ABCI AM manages one SFC-authorised fund and six private funds as at 31 December 2021 with investment objectives to achieve medium to long term capital growth and asset class covering fixed income, public-traded equity and private equity primarily in Greater China. The investment portfolio of the funds spans across various sectors including technology, consumer and new retail, and healthcare, which are also the target sectors for the De-SPAC Transactions. ABCI AM has also been approved by the China Securities Regulatory Commission with the Qualified Foreign Institutional Investor and Renminbi Qualified Foreign Institutional Investor qualifications, which allows foreign investors to access the PRC onshore capital market. ABCI AM, together with ABCI’s onshore entities, manages more than 70 funds with total capital commitments of over RMB100 billion as of the Latest Practicable Date and has extensive experience in investment transactions. Their investment portfolio spans across the infrastructure, smart agriculture, new energy and urban renewal sectors, often with funding support from a wide array of financing partners, including government-led industry funds, state-owned enterprises and financial institutions. ABCI AM managed assets with an average collective value of approximately HK$14.4 billion, HK$15.4 billion and HK$10.4 billion in 2019, 2020 and 2021, respectively. Source: Interra Acq-Z (07801) Prospectus (IPO Date : 09/09/2022)
Listing Market	MAIN
Industry	Special Purpose Acquisition Company
Background	Others
Major Business Area	N/A

Corporate Information

Substantial Shareholders	Primavera Capital Acquisition (Asia) LLC (Total share: 41.73%) [01288] Agricultural Bank of China Limited (Total share: 27.82%)
Directors	CHEN Tong (Co-Chairman and Co-Chief Executive Officer and Executive Director) YANG Xiuke (Co-Chairman and Co-Chief Executive Officer and Executive Director) GE Chengyuan (Co-Chief Financial Officer and Executive Director) MING Liang (Executive Director) CHAN Ching Chu (Independent Non-Executive Director) CHAN Jeanette Kim Yum (Independent Non-Executive Director) PU Yonghao (Independent Non-Executive Director)
Company Secretary	Lee Leong Yin
Principal Bankers	Bank of China (Hong Kong) Limited
Solicitors	Davis Polk & Wardwell
Auditors	KPMG
Registered Office	5th Floor, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong
Share Registrars	Tricor Investor Services Ltd. [Tel: (852) 2980-1333]
Share Registrars Tel No	(852) 2980-1333
Internet Address	https://www.interraacquisition.com
Email Address	ir@interraacquisition.com
Tel No
Fax No

Real-time Futures	IPO Plus	Company Announcement
Top 20	Highs/ Lows	Company Dividend
Local Indices	DTDC RMB Traded Stocks	Result Announ. Schedule
World Indices	BioTech Stocks	Research Report
China Indices	Second Listing Stocks	Result Announ. News
Index Constituents	Short Selling	Corp. Event Search
H Shares (All)	ADR	Economic Calendar
Red Chips (All)	A+H+ADR	Economic Database
GEM (All)	A+H	Economic Data Chart
Industries	Shareholding Disclosures	World Interest Rates